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Abstract
Background: The goal of this study was to evaluate the prevalence of depression and anxiety in patients subjected to 
myocardial perfusion imaging (MPI) with 99mTc tetrofosmin stress-rest single-photon emission computer tomography (SPECT), 
and their impact on their cardiological events or disease.
material and methods: Patients referred to the Nuclear Medicine Department for 99mTc tetrofosmin myocardial MPI-SPECT 
were asked to fulfill the Zung Self-Rating Depression Scale (ZDS) and Hamilton anxiety questionnaire (HAQ). Among 213 pa-
tients who completed the ZDS and HAQ, 80 patients (59 males and 21 females) were selected for this study because they had 
no known psychological disease, other disease that could influence psychological status, or use of narcotic drugs. Collected 
data from MPI and psychological status were subsequently analyzed.
results: Among all 80 patients, 52 patients (65%) had abnormal MPI of whom 28/52 (53.8%) exhibited either depression, 
anxiety or both, and 28 (35%) patients had normal MPI of whom 10/28 (35.7%) had abnormal psychological status. The higher 
number of patients with abnormal psychological status in association with abnormal MPI was noted predominantly in patients 
with previously established coronary artery disease. A correlation was also noted between obesity, cardiac heredity and de-
pression or anxiety in patients with abnormal MPI.
conclusions: Patients that exhibit depression, anxiety, or both, have high rates of myocardial ischemia, and thus are at 
risk for subsequent cardiological events. 
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Introduction
Anxiety and depression are frequently manifested in pa-
tients with cardiovascular diseases. Prevalence may vary between 
15 and 50%, according to diagnostic criteria used and demographic 
characteristics of the patients [1]. Depression may be associated 
with coronary artery disease (CAD) and its consequences such 
as cardiac arrhythmias, myocardial infarction (MI) and heart failure. 
Although the exact physiological mechanisms for this association 
remain unclear, it may be due to hypothalamic – pituitary dysregula-
tion, altered immune function or existence of common unknown risk 
factors for both medical conditions [2, 3]. Scientific evidence over 
the last few years reported significant association between anxiety 
or depression and various organic conditions including cardiac 
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diseases [1, 4]. Furthermore, patients with cardiac diseases and 
depression tend to exhibit poor risk factor control resulting into 
further deterioration of their cardiac disease and prognosis [1]. 
Anxiety has been also linked to increased mortality in patients with 
CAD but this association was reported less strong than that of 
depression [5]. It is interesting that anxiety seems to improve in 
patients that have detailed imaging studies concerning their disease 
and good communication with their physician about the status of 
their medical condition [6]. 
Myocardial perfusion imaging (MPI) SPECT may be used to 
assess the myocardial condition either in patients with known MI, 
or post either percutaneous transluminal coronary angioplasty 
(PTCA) or coronary artery bypass grafting(CABG)[7], or with silent 
myocardial ischemia due to non-specific cardiac complaints [8–10]. 
The MPI grading may be able to provide an excellent tool to 
monitor response to treatment, follow-up status and long term 
prognosis [11, 12].
Women overall appear to display more nonspecific car-
diac complaints than men. However, these symptoms by them-
selves have unknown clinical significance not necessarily linked 
to myocardial ischemia in the absence of other relative clinical 
manifestations [10]. However, MPI may be able to identify myo-
cardial ischemia in elderly women with angina or in asymptomatic 
women with concomitant diabetes mellitus or hypertension [13]. 
Female patients with CAD demonstrate positive MPI [14] with 
sensitivity of 87.16% and specificity of 97% [15]. In such cases, 
a summed stress score (SSS) ≥ 14 denoted an increased risk for 
cardiac events and an SSS ≥ 22 for subsequent significant cardiac 
events such as acute MI and cardiac death [16].
In the present retrospective study, we evaluated the rate of 
myocardial ischemia in patients who were subjected to MPI with 
99mTc-TF-SPECT, due to non-specific cardiac complaints of vari-
ous types, or in patients that had known myocardial disease for 
follow up after CABG or PTCA. Furthermore, in all patients we 
evaluated the association of anxiety and/or depression with the 
known cardiovascular risk factors such as age, smoking, obesity, 
diabetes mellitus (DM), arterial hypertension, dyslipidemia and 
cardiac heredity.
Material and methods
Patients
In the present study there were 80 patients, 59 men and 
21 women, that had MPI either for non-specific cardiac symp-
toms (workup to rule out CAD), or patients with known CAD and 
previous PTCA or/and CABG for follow up of their myocardial status. 
Cardiac risk factors were noted in each patient’s medical history 
(obesity, smoking, arterial hypertension, diabetes mellitus, dyslipi-
demia, and cardiac heredity). Patients were considered as smok-
ers when smoking habits were active or stopped during the last 
3 months. Females under anti-hypertensive drugs or with systolic 
blood pressure (BP) ≥ 140 mm Hg or diastolic BP ≥ 90 mm Hg were 
noted as having hypertension as risk factor. Diabetes mellitus as risk 
factor was noted in females under antidiabetic medication and 
fasting glucose > 126 mg/dL. Finally, dyslipidemia was consid-
ered in patients receiving therapy with statins or exhibiting fasting 
cholesterol level > 220 mg/dL.
SPECT MPI 
All study participants had been subjected to 99mTc-TF-SPECT 
before and after stress using a 1-day imaging protocol according 
to published guidelines [17]. Stress protocol was consisted either 
of a dynamic exercise (Bruce protocol treadmill exercise test) or 
a pharmacological test with either dipyridamole or dobutamine. 
The electrocardiography was continuously monitored during stress. 
All patients were first injected with 8 mCi Tc-99m tetrofosmin after 
stress or 20 mCi at rest followed by acquisition of images 40 minu-
tes later via a 90°-angled dual-head camera, employing a collimator 
with 64 stops and 25 s per projection over a 180° arc. Reconstruc-
tion of images was consisted of filter back projection without at-
tenuation correction [18].
MPI was visually evaluated by two nuclear medicine specialists, 
using a 17 scoring each segment on a scale of 0 to 4 according 
to the severity of the myocardial perfusion deficit [18].Thus, score 
0 was designated when there was no decreased myocardial ac-
tivity, score 1with mildly decreased activity, score 2 for moderate 
decreased activity, score 3 for severely decreased activity and 
score 4 for absent tracer activity. All individuals scores at rest 
and stress were combined and produced the summed rest score 
(SRS) and summed stress score (SSS). The difference of the two 
scores (S-RSS) was also calculated and evaluated. A summed 
difference score (SDS) was obtained by subtracting the rest score 
from the stress score; in the presence of a reversible defect (or 
ischemia) the score was positive. Myocardial ischemia (MIS) 
was graded as mild when SSS was 4 to 8, moderate from 9 to 13, 
and severe when SSS over 13 [19].
Evaluation of psychological status
Patients who were subjected to 99mTc-TF-SPECT- MPI in the 
Department of Nuclear Medicine were asked to fulfill the Zung 
Self-Rating Depression Scale (ZDS) and Hamilton anxiety question-
naire (HAQ). The ZDS consists of 20 items that quantify the depres-
sive symptoms of a patient. Each item is scored on a range from 
1 to 4. Total score lower than 50 is considered as normal, between 
50 and 59 as mild depression, between 60 to 69 as moderate de-
pression, while score over 70 as severe depression [20]. The HAQ 
consists of 14 items and is widely used to assess both psychic and 
somatic anxiety. Each item is scored on a range of 0 (not present) 
to 4 (severe anxiety), with a total score ranging from 0 to 56 [21].
Among the patients who agreed to participate to the study, 
those with known disease such as cancer, multiple sclerosis, chron-
ic kidney disease or any other condition that could influence psy-
chological status were excluded from the study. Furthermore, those 
with known psychological disease, use of narcotic drugs were also 
excluded. ZDS and HAQ results were evaluated by a psychiatrist.
Statistical analysis
The evaluation of the myocardial perfusion studies were 
analyzed utilizing the statistical software SPSS version 20 for 
windows (SPSS, Chicago, IL). Several groups of patients were 
developed based on the gender, the degree of abnormality and their 
correlation with the specific characteristics of depression, anxiety, 
obesity, cardiac heredity, smoking and hypertension. 
Baseline characteristics were described using, median and fre-
quencies for categorical variables. For the verification of correlation 
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“N-1” Chi-squared test has been utilized to determine the significant 
difference between the means of two groups, which may be related 
in certain features. The alpha of 0.05 was used as the cutoff for sig-
nificance and thus if the p-value was less than 0.05, the difference 
of the two groups was significant. Additionally, a Spearman’s rho 
methodology applied for the identification of the correlation among 
the different characteristics and features. A Spearman’s rank-order 
correlation between the groups of features provides a degree of 
correlation regarding the level of the rs score. Thus, rs of 0.2 to 
0.39 describe as weak correlation and 0.4 to 0.59 as moderate 
correlation, respectively.
Results
The patients’ age, medical history of myocardial infarction and 
cardiac risk factors are shown in Table 1. Abnormal MPI was found 
in 52 of 80 patients (65%), and normal MPI in 28/80 (35%) patients. 
Among all study participants with abnormal MPI 53.8% exhibited 
depression, anxiety or combination of both (Tab. 2). However, pa-
tients with normal MPI demonstrated lower rate of psychological ab-
normalities at 35.7%. Statistical analysis did not reveal any statistical 
significance possibly due to the small number of patients studied; 
however, a statistical trend was noted (p = 0.1244). Patients that 
had previously established CAG and had abnormal MPI performed 
for follow-up after PTCA or CABG had significantly higher rates of 
depression or anxiety (57.1%) compared to those that had normal 
MPI (28.6%). However, such a difference was less pronounced in 
patients that were undergoing MPI as an initial evaluation of myo-
cardial status for suspected CAD (Tab. 2). 
Furthermore, evaluation of the results according to sex dem-
onstrated that men had much higher percentage of abnormal MPI 
(47/59, 80%) compared to women (5/21, 24%) p < 0.0001 (Tab. 3). 
In addition, our results suggested that women had a higher rate 
of anxiety than men; however, due to the small numbers of female 
patients it was not able to document it statistically, even though 
a trend of statistical significance was noted, p = 0.1363.
In addition, a Spearman’s rank-order correlation was run to 
determine the relationship between the depression and anxiety 
with several cardiological risk factors. In patients with abnormal 
MPI, depression and anxiety found to have a moderate correlation 
(rs = 0.411, p = 0.001) and weak correlation (rs = 0.369, p = 0.001), 
retrospectively, with obesity. On the other hand, in normal MPI 
group, the obesity was only correlated weakly with the anxiety 
(rs = 0.351, p = 0.001). Another feature that appears correlation 
with the MPI patient’s condition is the cardiac heredity. Thus, weak 
correlation (rs = 0.231, p = 0.001) appeared for abnormal MPI 
patients between the cardiac heredity and the depression.  
Discussion
Depression and anxiety are frequently observed in patients with 
cardiovascular disease and linked with increased morbidity and 
poor prognosis. Apart from a possible direct effect on several 
cardiovascular risk factors such as blood pressure, they lead the 
patient into neglecting the physician-directed therapeutic interven-
tions and further deterioration of their cardiovascular status [22, 23].
In the present study, 80 patients were subjected to MPI in 
order to assess their myocardial status either as an initial evalu-
ation of possible CAD or as a follow-up of known CAD. Among 
all patients examined, 52 patients (65%) had abnormal MPI and 
28 (35%) normal examination. In the group with the abnormal 
table 1. Characteristics of the patients [mean value ± standard 
deviation (min-max)]
Characteristics All  
80 patients
Male  
59 patients
Females  
21 patients
Diagnostic MPI 45/80 (56%) 28/45 (62%) 17/45 (38%)
PTCA &CABG MPI 31/80 (39%) 27/31 (87%) 4/31 (13%)
Mean age [years] 66.69 ± 11.61 66.72 ± 11.15 66.57 ± 13.10 
Myocardial infarction 20/80 (25%) 17/80 (85%) 3/80 (15%)
Smoking 25/80 (11%) 19/25 (76%)  6/25 (24%)
Hypertension  59/80 (74%) 43/59 (73%) 16/59 (27%)
Diabetes mellitus 35/80 (44%) 28/35 (80%) 7/35 (20%)
Hyperlipidemia 54/80 (67%) 42/54 (78%) 12/54 (22%)
Obesity 26/80 (33%) 20/26 (77%) 6/26 (23%)
Heart heredity 27/80 (34%) 20/27 (74%) 7/27 (26%) 
MPI — myocardial perfusion imaging; PTCA — percutaneous transluminal coronary 
angioplasty; CABG — coronary artery bypass grafting
table 2. Rates of abnormal MPI, depression, anxiety, or both in 
patients subjected to myocardial scintigraphy either for diagnostic 
reasons or after cardiologic intervention (follow-up)
Psychologi-
cal status 
MPI (+) 52/80 (65%) MPI (–) 28/80 
(35%)
p 
All patients that had MPI (N = 80)
Depression 10/52 (19.2%) 3/28 (10.7%) 0.3284
Anxiety 13/52 (23.1%) 4/28 (14.3%) 0.3512
Both 5/52 (9.6%) 3/28 (10.7%) 0.8764
Total 28/52 (53.8) 10/28 (35.7%) 0.1244 *
MPI performed for diagnostic reasons (N = 45)
Depression 3/24 (12.5%) 2/21 (9.5%) 0.7520
Anxiety 6/24 (25%) 3/21 (14.3%) 0.3761
Both 3/24 (12.5%) 4/21 (19%) 0.5526
Total 12/24 (50%) 9/21 (42.9%) 0.7471
MPI performed after cardiologic intervention (PTCA, CABG or both) 
(N = 35)
Depression 7/28 (25%) 1/7 (14.3%) 0.5523
Anxiety 7/28 (25%) 1/7 (14.3%) 0.5523
Both 2/28 (7.1%) 0/7 (0.0 %) 0.4743
Total 16/28 (57.1%) 2/7 (28.6%) 0.1835 *
MPI (–) — Normal myocardial perfusion imaging; MPI (+) — Abnormal myocardial 
perfusion imaging; PTCA — Percutaneous transluminal coronary angioplasty; CABG — 
Coronary artery bypass grafting; * — a trend of statistical significance
table 3. Patients with abnormal MPI and depression, anxiety, or both
Sex No MPI (+) Depression Anxiety Both 
Male 59 47/59 (80%)  
p < 0.0001**
9/47 (19%)  
p = 0.921
11/47 (23%) 
p = 0.1363*
4/47 (9%)  
p = 0.5631
Female 21 5/21 (24%) 1/5 (20%) 2/5 (40%) 1/21 (5%)
Total 80 52/80 (65%) 10/52 (19%) 13/52 (25%) 5/52 (8%)
MPI — Myocardial perfusion imaging; MPI(+) — Abnormal myocardial perfusion imaging; 
PTCA — Percutaneous transluminal coronary angioplasty; CABG — Coronary artery bypass 
grafting; p* — trend of statistical significance; p** — statistical significance
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MPI, 53% exhibited depression (19.2%), anxiety (23.1%) or both 
(9.6%). In contrast only 35.7% (p = 0.1244/indicating a trend of 
statistical significance) of patients with negative MPI exhibited 
any psychological abnormality (depression 10.7%, anxiety 14.3%, 
both 10.7%) (Tab. 2). This trend towards statistical significance of 
increased frequency of psychological abnormalities in patients with 
positive MPI, but not definite statistical significance, may be due 
to the relative small number of patients. It suggests though that 
psychological abnormalities may predispose to the development 
of CAD, independently of the other well established risk factors. 
Interestingly, in our study, these differences were more pronounced 
in the group of patients with known CAD, undergoing the MPI for 
follow up rather than the group that test for diagnostic purposes, 
supporting the same conclusion. Definitely, larger studies are 
needed to verify these findings. A prospective cross-sectional study 
of 314 patients presented with chest pain showed a significant 
association between degree of depression and CAD in female 
patients [24]. Similar results of female predominance of depressive 
symptoms as well as higher incidence of anxiety and CAD were 
reported in a Chinese study [25]. Another large study in 514 German 
CAD patients, evaluated by the Mini International Neuropsychiatric 
Interview and the Global Assessment of Functioning (GAF) scale 
demonstrated comorbidity of depression with CAD and treatment 
of the depression resulted in improvement of this condition [26]. 
Interestingly, patients undergoing CABG operation, depression 
and anxiety were increased after the operation compared to the 
pre-operative period [27].
Evaluation of our results according to sex, demonstrated pre-
dominance of men rather than women as having abnormal MPI and 
thus CAD (Tab. 3). In addition, although our findings suggested that 
women had a higher rate of anxiety than men, the numbers of fe-
male patients were too small to establish any significance; however, 
with caution we noted a trend of statistical significance. A previ-
ous study in patients undergoing MPI for assessing myocardial 
status in patients with known or unknown CAD was consisted with 
our findings showing high level of anxiety mostly in women prior 
to the examination [28]. Other studies in women reported positive 
MPI findings in 32% [29], and a sensitivity of 91% and specificity 
of 70% when SSS was > 8 [30]. In general, patients with anxiety 
disorders or co-existence of anxiety/depression are associated with 
increased prevalence of coronary heart disease [31]. Although in 
some studies depression seems to be the most important factor 
associated with CAD [32, 32], other studies indicate anxiety as the 
predominant psychological factor contributing to CAD [31]. Nev-
ertheless, co-existence of both psychological factors appears to 
have added validity towards this regard. A study on 118 men 
without history of psychological disturbances demonstrated that 
after CABG, 16–39.8% of them developed depression and 27.1% 
anxiety independent of CAD severity [33]. However, female pa-
tients demonstrate further reduced quality of life after a cardiac 
event compared to men. This quality of life refers to appearance 
anxiety, depression and low self-esteem among other things and 
may last for over one year [34]. In another study, the reported 
rates of CAD in female veterans’ patients were 4.16%, reaching 
up to 36% when patients were smokers. Furthermore, those with 
depression had 60% higher chance of CAD [35].
The mechanisms that the described psychological param-
eters contribute to the development of CAD are not very well 
defined and could be multi sequential. Some investigators suggest 
that somatic-vegetative features of depression may be linked at 
an early stage to the development of coronary artery disease [36]. 
In our study, obesity and cardiac heredity were also associated 
with depression and anxiety. Previous studies have described 
an association between hypertension and anxiety, and both de-
pression and anxiety have been linked to diabetes mellitus [37] 
and hypercholesterolemia [38]. 
Conclusions
In conclusion, our results showed that patients with myocardial 
dysfunction, as evident by abnormal MPI, have increased frequency 
of coexisting depression, anxiety or both, suggesting that these 
factors may be contributing risk factors. In addition, both males and 
females were at higher risk for CAD if depression and anxiety were 
combined with obesity or cardiac heredity. Further larger studies are 
needed to verify these findings.
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